横导管边缘到边缘的修复,以使 mitra 反
Philipp von Stein1, Christos Iliadis2
1Department III of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Cardiovascular Research Foundation, New York, NY, USA.
Trends in cardiovascular medicine
|February 13, 2025
概括
跨导管边缘到边缘修复 (M-TEER) 提供了一种安全和有效的治疗对手腕吐 (MR). 最近的试验改进了对这种微创手术的患者选择,特别是对二次MR的选择.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 副腹 (MR) 带来了重大挑战,特别是对于那些无法接受手术的患者.
- 过导管端到端修复 (M-TEER) 已成为一个关键的治疗选择.
- 具有里程碑意义的试验 (EVEREST II,COAPT,MITRA-FR) 确定了M-TEER在初级和二级MR中的安全性和有效性.
研究的目的:
- 审查关于M-TEER对额头上的关键试验证据.
- 讨论M-TEER的最佳患者选择和治疗指示,特别是在二次MR中.
- 探索设备的进步和M-TEER治疗的未来方向.
主要方法:
- 对里程碑和最近的临床试验进行了全面的审查 (EVEREST II,COAPT,MITRA-FR,RESHAPE-HF2,MATTERHORN).
- 对M-TEER患者选择标准和治疗结果的分析.
- 讨论不断发展的设备技术和正在进行的研究.
主要成果:
- M-TEER证明了对初级和二级MR的安全性和有效性.
- 最近的试验 (RESHAPE-HF2, MATTERHORN) 提供了对M-TEER患者的患者选择和SMR表型的见解.
- 证据支持M-TEER作为选择MR患者手术的有价值替代方案.
结论:
- M-TEER是一种转变性治疗额头肌吐的疗法,越来越多的证据支持其使用.
- 精细的患者选择,特别是对二次MR表型的选择,对于最佳的M-TEER结果至关重要.
- 目前正在进行的试验和设备创新将继续塑造M-TEER实践的未来.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...